Anna Stoliaroff-Pepin, Caroline Peine, Tim Herath, Johannes Lachmann, Wiebke Hellenbrand, Delphine Perriat, Achim Dörre, Andreas Nitsche, Janine Michel, Marica Grossegesse, Natalie Hofmann, Thomas Rinner, Claudia Kohl, Annika Brinkmann, Tanja Meyer, Daniel Stern, Fridolin Treindl, Brigitte G Dorner, Sascha Hein, Laura Werel, Eberhard Hildt, Sven Gläser, Helmut Schühlen, Caroline Isner, Alexander Peric, Ammar Ghouzi, Annette Reichardt, Matthias Janneck, Guntram Lock, Dominik Huster, Thomas Grünewald, Lars Schaade, Ole Wichmann, Thomas Harder
PURPOSE: COViK, a prospective hospital-based multicenter case-control study in Germany, aims to assess the effectiveness of COVID-19 vaccines against severe disease. Here, we report vaccine effectiveness (VE) against COVID-19-caused hospitalization and intensive care treatment during the Omicron wave. METHODS: We analyzed data from 276 cases with COVID-19 and 494 control patients recruited in 13 hospitals from 1 December 2021 to 5 September 2022. We calculated crude and confounder-adjusted VE estimates...
March 13, 2023: Infection